ETF Holdings Breakdown of AUTL

Stock Name	Autolus Therapeutics Ltd
Ticker	AUTL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US05280R1005
LEI	549300C0KZP8EYROLL02

News associated with AUTL

Renaissance Technologies LLC Purchases 368,071 Shares of Autolus Therapeutics plc (NASDAQ:AUTL): Renaissance Technologies LLC lifted its holdings in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 146.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 618,942 shares of the company’s stock after purchasing an additional 368,071 shares during the period. Renaissance Technologies LLC’s holdings in Autolus Therapeutics were worth $1,455,000 as of its most recent […] - 2025-04-29 07:44:58
Autolus Therapeutics (NASDAQ:AUTL) Given New $10.00 Price Target at Truist Financial: Autolus Therapeutics (NASDAQ:AUTL – Free Report) had its price objective trimmed by Truist Financial from $11.00 to $10.00 in a report published on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other analysts have also recently weighed in on the company. Needham & Company LLC reaffirmed a “buy” rating and […] - 2025-04-02 07:14:47
Autolus Therapeutics plc (NASDAQ:AUTL) Receives Average Rating of “Buy” from Analysts: Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) has been given a consensus recommendation of “Buy” by the six brokerages that are covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in the […] - 2025-03-26 05:53:00
Daiwa Securities Group Inc. Has $56,000 Stock Position in Autolus Therapeutics plc (NASDAQ:AUTL): Daiwa Securities Group Inc. grew its stake in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 55.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 23,743 shares of the company’s stock after purchasing an additional 8,479 shares during the quarter. Daiwa […] - 2025-03-18 07:42:52
Autolus Therapeutics plc (NASDAQ:AUTL) Shares Bought by Handelsbanken Fonder AB: Handelsbanken Fonder AB boosted its position in shares of Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 30.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,300 shares of the company’s stock after buying an additional 17,300 shares during […] - 2025-03-04 08:46:54

AUTL institutional holdings

The following institutional investment holdings of AUTL have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 101,823 USD 137,461

2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 101,823 USD 137,461 8.9%

Total = 203,646 USD 274,922
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	101,823	USD 137,461
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	101,823	USD 137,461 8.9%
Total =	203,646	USD 274,922

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.